	Compliance or Consequences Remember, the U.S. government set January 1, 2008, as the deadline for demonstrating full compliance with United States Pharmacopeia Chapter 797, “Pharmaceutical Compounding: Sterile Preparations.” Pharmacies inspected anytime after that date that fail to comply are risking exposure to patient lawsuits and/or potential loss of JCAHO accreditation.

	Complimentary Audit

Complete USP 797 Compliance Solutions

Welcome to the Pharmacy Director’s single source for total USP 797 compliance that’s professional, efficient, and cost-effective.

Don’t have the experience necessary for compliance management? Or can’t afford to divert internal resources? Microtest is your ideal turnkey solution.

Microtest is the source for consulting services, laboratory testing, pharmaceutical manufacturing and regulatory response expertise, and environmental monitoring. We have everything that directors of sterile drug compounding pharmacies require both within hospitals and independent operations to respond to their urgent compliance requirements.

Unlike other compliance vendors, Microtest avoids the pitfalls of a partial solution: insufficient experience, inadequate capabilities, or poor follow-through.

Microtest offers a full menu of must-have services




	THE COMPLIANCE DILEMMA: Problems and Solutions in Meeting USP 797 Regulations for Compounding Pharmacies

	Download this free white paper now.

Compliance or Consequences

Complete USP 797 Compliance Solutions